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Background: Intermittent pneumatic compression (IPC) is an effective method of leg inflow enhancement and ameliora-
tion of claudication in patients with peripheral arterial disease. This study evaluated the clinical efficacy of IPC in patients
with chronic critical limb ischemia, tissue loss, and nonhealing wounds of the foot after limited foot surgery (toe or
transmetatarsal amputation) on whom additional arterial revascularization had been exhausted.
Methods: Performed in a community and multidisciplinary health care clinic (1998 through 2004), this retrospective study
comprises 2 groups. Group 1 (IPC group) consisted of 24 consecutive patients, median age 70 years (interquartile range
[IQR], 68.7-71.3) years, who received IPC for tissue loss and nonhealing amputation wounds of the foot attributable to
critical limb ischemia in addition to wound care. Group 2 (control group) consisted of 24 consecutive patients, median age 69
years (IQR, 65.7-70.3 years), who received wound care for tissue loss and nonhealing amputation wounds of the foot due to
critical limb ischemia, without use of IPC. Stringent exclusion criteria applied.Group allocation of patients depended solely on
their willingness to undergo IPC therapy. Vascular assessment included determination of the resting ankle-brachial pressure
index, transcutaneous oximetry (TcPO2), duplex graft surveillance, and foot radiography. Outcome was considered favorable
if complete healing and limb salvage occurred, and adverse if the patient had to undergo a below knee amputation subsequent
to failure of wound healing. Follow-up was 18 months. Wound care consisted of weekly débridement and biologic dressings.
IPCwas delivered at an inflation pressure of 85 to 95mmHg, applied for 2 seconds with rapid rise (0.2 seconds), 3 cycles per
minute; three 2-hourly sessions per day were requested. Compliance was closely monitored.
Results: Baseline differences in demography, cardiovascular risk factors (diabetes mellitus, smoking, hypertension, dyslipide-
mia, renal impairment), and severity of peripheral arterial disease (ankle-brachial indices, TcPO2, prior arterial reconstruction)
were not significant. The types of local foot amputation that occurred in the two groups were not significantly different. In the
control group, foot wounds failed to heal in 20 patients (83%) and they underwent a below knee amputation; the remaining
four (17%, 95% confidence interval [CI], 0.59%-32.7%) had complete healing and limb salvage. In the IPC group, 14 patients
(58%, 95% CI, 37.1%-79.6%) had complete foot wound healing and limb salvage, and 10 (42%) underwent below knee
amputation for nonhealing foot wounds.Wound healing and limb salvage were significantly better in the IPC group (P< .01,
2). Compared with the IPC group, the odds ratio of limb loss in the control group was 7.0. On study completion, TcPO2 on
sitting was higher in the IPC group than in the control group (P  .0038).
Conclusion: IPC used as an adjunct to wound care in patients with chronic critical limb ischemia and nonhealing
amputation wounds/tissue loss improves the likelihood of wound healing and limb salvage when established treatment
alternatives in current practice are lacking. This controlled study adds to the momentum of IPC clinical efficacy in critical
limb ischemia set by previously published case series, compelling the pursuit of large scale multicentric level 1 studies to
substantiate its actual clinical role, relative indications, and to enhance our insight into the pertinent physiologic
mechanisms. (J Vasc Surg 2008;47:543-9.)In most vascular units, 50% to 60% of patients present-
ing with critical limb ischemia (CLI) may be considered for
some form of revascularization.1,2 Yet this figure, which
may be as high as 90% in specialized tertiary centers, and the
contemporary medical and technical advances have resulted
in only a modest decrease in the proportion of those with
CLI ending in amputation.1,2 Longitudinal comparisons of
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doi:10.1016/j.jvs.2007.11.043the total number of amputations performed during a
longer time span indicate an increase, ascribed to the aging
population.1,3,4 It is projected that this may lead to the num-
ber of major amputations being doubled within 30 years.1
By acutely enhancing the arterial leg inflow,5 intermittent
pneumatic compression (IPC) of the leg has been shown to
improve the walking ability, arterial hemodynamics, and qual-
ity of life of patients with severe peripheral arterial disease
(PAD).6,7 Well-tolerated in domestic use (compliance
82%), IPC of the leg increased claudication distance by
200% or more while causing the resting and postexercise
ankle-brachial pressure index (ABI) to rise by 17% and 64%,
respectively, thus implicating collateral circulation enhance-
ment.6 Further studies have indicated that high-pressure IPC
might be able to allow limb salvage in patients with severe
infrapopliteal disease8 and limb-threatening ischemia who are
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matic compression increases axial, muscular, collateral, and
skin blood flow in patients with PAD5,12 and CLI.13 This
evidence in the paucity of established methods of treatment
when revascularization fails or is not feasible3 prompted us to
evaluate the clinical efficacy of IPC in patients with chronic
nonhealing amputation wounds of the foot and tissue loss
attributable to CLI on whom all means of additional revascu-
larization had been exhausted.
METHODS
Institutional Review Board approval was granted be-
fore data were accumulated and analyzed. This is a retro-
spective controlled study pursued in a multidisciplinary
wound-healing outpatient’s clinic comprising orthopedics,
vascular surgery, and vascular medicine services. Consid-
ered for inclusion were consecutive patients with chronic
nonhealing toe or transmetatarsal amputation wounds and
tissue loss of the foot attributable to chronic CLI,3 on
whom all means of additional revascularization had been
exhausted. Excluded were those with tissue loss of mixed
cause (ie, venous, vasculitic, neuropathic, infective, trau-
matic); those who underwent alternative means of CLI
treatment in the course of the study, including vasoactive
pharmacotherapy (ie, prostaglandins) and epidural analge-
sia, as a means of enhancing their healing response to the
Table I. Baseline demography, cardiovascular risk factors
Control) and the group of those who received intermitten
Demography, Risk Factors Group IPC (n
Age, median (IQR) years 70 (68.7-71.
Men 18 (75%)
Women 6 (25%)
Men / Women Ratio 3
Cardiovascular Risk Factors
Coronary Artery Disease 17 (71%)
Prior Revascularization 19 (79%)
Diabetes Mellitus 15 (63%)
Insulin Dependent 13 (62%)
Non-Insulin Dependent 2 (10%)
Glycosylated Hemoglobin (8%) 18 (75%)
Median (IQR) 7 (6.72-7.8
History of Hypertension 14 (58%)
Dyslipidemia 16 (67%)
On Statin Therapy 13 (54%)
Smoking
Current 3 (13%)
Former 20 (83%)
Never 4 (17%)
Chronic Renal Failure
Serum Creatinine median (IQR) 1.2 (1.1-1.8)
Hemodialysis 5 (21%)
Baseline Infection in the Foot
Osteomyelitis 18 (88%)
IPC, Intermittent pneumatic compression; NS, not statistically different.
aDifferences in proportions between the two groups are based on the 2 witissue loss; those with deep vein thrombosis sustained 6months of the study inclusion or during the study course,
and finally, those with calf wounds.
Conducted from January 1998 through December
2004, the study comprised two groups managed concur-
rently. The active treatment group (IPC group) consisted
of 24 consecutive patients with a median age of 70 years
(interquartile range [IQR], 68.7-71.3 years) who received
IPC for tissue loss and nonhealing amputation wounds of
the foot attributable to chronic CLI, in addition to a
standardized wound care regimen. The control group
(control group) also consisted of 24 consecutive patients
with a median age of 69 years (IQR: 65.7-70.3) years who
received a standardized wound care regimen for tissue loss
and nonhealing amputation wounds of the foot due to
chronic CLI, without the use of IPC. Group allocation
depended solely on the patients’ willingness to undergo
IPC therapy. Demographic data of the study groups are in
Table I. Baseline arterial evaluation of the patients in both
study groups is summarized in Table II.
Vascular assessment included measurement of the resting
ABI, duplex ultrasound scanning for lower limb arterial exam-
ination, graft surveillance, and exclusion of deep vein throm-
bosis and chronic venous stasis, in addition to leg radiography
or magnetic resonance imaging or both. The functional eval-
uation of cutaneous blood flow was assessed with transcuta-
neous oximetry (TcPO2) in the supine and dependent (10
steomyelitic foot infection in the control group (Group
umatic compression (Group IPC)a
Group Control (n24) Significance
69 (65.7-70.3) NS*
16 (67%) NS
8 (33%) NS
2 —
18 (75%) NS
19 (79%) NS
17 (71%) NS
5 (11%) p0.02
12 (20%) p0.01
20 (83%) NS
6.9 (6.2-7.98) NS*
20 (83%) NS
20 (83%) NS
17 (71%) NS
3 (13%) NS
14 (58%) NS
4 (17%) NS
1.2 (1.17-1.85) NS*
5 (21%) NS
24 (100%) NS
es correction unless otherwise stated (* Mann Whiteny test).and o
t pne
24)
3)
5)minutes) positions performed with electrodes (temperature,
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and in the hindfoot, calf, and thigh (minimum of 4 probes)
with airtight adhesive (normal, 45 mm Hg; mild ischemia,
40-45 mm Hg; moderate ischemia, 20-39 mm Hg; severe
ischemia 20 mm Hg), Used for the purposes of this study
were the lowest TcPO2 values per posture and limb, appar-
ently associated with the foot site of ischemia. The protocol of
laboratory assessments performed during the study period is
schematically presented in Table III. Patients enrolled in the
study were followed up for 18 months. Surgical outcomes
were considered favorable if complete healing occurred and
the treated limb was salvaged. An unfavorable outcome was
noted if the patient had to undergo a below knee amputation
(BKA) subsequent to failure of healing and deterioration of
the amputation wound.
All patients received a standard wound care regimen
consisting of weekly débridement and biologic dressings
with cadexomer iodine (Iodosorb, Smith & Nephew, Lon-
don, UK), provided by a home health care agency under
the supervision of the authors, and monthly surveillance at
the wound center. Cadexomer iodine gel (Iodosorb), a
standard adjunct in wound care, was added for its antimi-
crobial properties and tissue granulation enhancement.14
Intermittent pneumatic compression of the calf was
delivered using the ArterialFlow (DJO, Vista, Calif), a
mechanical pneumatic pump consisting of a pneumatic
impulse generator and a plastic inflatable pad (length, 29
cm; maximum circumference, 48 cm), specially designed to
fit the calf. Large-bore elastic tubing connects the unit with
the pad. The pump throughout the study was set to operate
at a maximum inflation pressure of 85 to 95 mm Hg,
delivered for 2 seconds with a rise time of 0.2 seconds, and
Table II. Baseline arterial status and amputations of patie
those receiving intermittent pneumatic compression (Grou
Baseline Arterial Status Group IPC (n24
Transcutaneous Oximetry
(TcPO2)
0-20 mmHg 10 (42%)
21-30 mmHg 14 (58%)
Resting ABPI median (IQR) 0.55 (0.44-0.68)
Prior Arterial Reconstruction 19 (79%)
Femoro-popliteal Bypass 4 (17%)
Femoro-distal Bypass 15 (63%)
Femoro-peroneal 7 (29%)
Femoro-dorsalis pedis 5 (21%)
Femoro-medial-plantar artery 3 (13%)
Amputations
Digit 14 (58%)
Ray 7 (29%)
Trans-metatarsal 7 (29%)
IPC, Intermittent pneumatic compression; IRQ, interquartile range; NS, n
aStudy patients, all with active foot ulcers, either had a TcPO2 of 30 mmH
meeting contemporary TASCII criteria for critical limb ischemia. Differences
unless otherwise stated (** Mann Whitney test).a deflation pressure of 0 mmHg of 18 seconds’ duration. Aminimum of 6 hours of IPC application per day, in three
2-hour sessions, was requested. A 24-hour help-line was
offered for pertinent emergencies or medical advice.
Patient compliance was monitored by means of a record-
ing device built-in the IPC pump and a patient logbook. As
the IPC pumps were regularly inspected for optimal function,
the IPC application time reported in the patient logbook was
compared with that of the recording device.
Analysis of the study data was performed with nonpara-
metric statistics.15 Quantitated paired data comparisons be-
tween the initial and study completion TcPO2 values were
conducted with the Wilcoxon sign ranked test. Comparisons
of quantitated nonpaired data for age, ABI, and TcPO2 be-
tween the IPC group and the control group, both at baseline
and at study completion, were conducted with the Mann-
Whitney test. For those who died before study completion at
18 months, the data last accumulated were considered for an
intention-to-treat analysis. The 95% confidence interval (CI)
the control group (Group Control) and the group of
C)a
Group Control (n24) Significance (2)
12 (50%) NS
12 (50%) NS
0.52 (0.45-0.65) NS**
16 (67%) NS
6 (25%) NS
10 (42%) NS
5 (21%) NS
3 (13%) NS
2 (8.5%) NS
15 (63%) NS
6 (25%) NS
3 (13%) NS
istically different.
ss or had an absolute ankle pressure of less than 70 mmHg, or both, thus
portions between the two groups are based on the 2 with Yates correction,
Table III. Working protocol of investigations in the two
study groups
Study baseline Study completiona
IPC
group
Control
group
IPC
group
Control
group
Clinical exam    
ABI determination    
TcPO2 determination    
ABI, Ankle-brachial index; TcPO2, transcutaneous oximetry.
aFollow-up lasted 18 months. In patients who died at 12 months, the
assessments made when they were last examined were included.nts in
p IP
)
ot statof the estimated median difference (Wilcoxon test), point
note t
re tha
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quoted. Bonferroni correction was applied, if appropriate.
Differences in proportionwere assessedwith the2 test. AP
.05 was considered significant. Data are expressed as median
and interquartile range (IQR).
RESULTS
Failure to meet the study criteria resulted in the exclusion
of 19 potential recruits, leading to a dropout rate of 28.4%.Of
those, 7 hadmixed etiology ulcers (37%), 5 had received other
treatments (ie, vasoactive drugs) for CLI in addition to IPC
(26%), another 4 (21%) had sustained deep vein thrombosis in
the limb with CLI6 months of their potential recruitment,
and 2 (11%) had additional ulcers in the calf.
The baseline differences in the age, the male/female
ratio, and the associated cardiovascular risk factors (diabe-
tes, smoking, hypertension, dyslipidemia, renal impair-
ment) were not significantly different between the two
study groups (Table I). This was also true for the baseline
ABIs, TcPO2, the extent and type of prior arterial recon-
struction, and the type of PAD (Table II). The location of
tissue loss or foot ulceration, or both, as well as the distri-
bution of the local foot amputation procedures performed
in the study course or 3 months before the commence-
ment of the study, are presented in Table II. Study patients,
all with active foot ulcers, either had a TcPO2 of 30 mm
Hg or had an absolute ankle pressure of 70 mm Hg, or
both, thus meeting contemporary TransAtlantic Inter-
Society Consensus (TASC) II criteria3 for critical limb
ischemia. Two grafts in the IPC group (1 femoral–peroneal
and 1 femoral–dorsalis pedis) and 2 grafts in the control
group (1 femoral–popliteal and 1 femoral–dorsalis pedis)
Table IV. Patency and graft or anastomotic stenosis ( 5
groups at the time study patients were recruiteda
Prior Arterial
Grafting/Reconstruction
Femoro-popliteal Bypass 4 in 4
Femoro-distal Bypass 13 in
Femoro-peroneal 6 in 7
Femoro-dorsalis pedis 4 in 5
Femoro-medial-plantar artery 3 in 3
Total 17 in
Prior Arterial
Grafting/Reconstruction
Femoro-popliteal Bypass 5 in 6
Femoro-distal Bypass 9 in 1
Femoro-peroneal 5 in 5
Femoro-dorsalis pedis 2 in 3
Femoro-medial-plantar artery 2 in 2
Total 14 in
IPC, Intermittent pneumatic compression.
aThere were no cases of graft or anastomotic stenosis exceeding 50%. Please
but they preceded the study patients’ recruitment by several years, often mohad been found occluded on graft surveillance with duplexultrasound imaging 12 weeks before the referral of pa-
tients for treatment at our institution. Patency or stenoses
of the grafts, or both, in patients who had previously
(months up to 5 years) undergone arterial revasculariza-
tion in the two study groups are summarized in Table IV.
The local foot amputation failed to heal in 20 patients
(83%) in the control group and they required BKA (Table V).
The remaining four (17%, 95% CI, 0.59%-32.7%) had com-
plete healing and limb salvage. However, 14 patients (58%,
95% CI, 37.1%- 79.6%) in the IPC group had complete
healing and subsequent limb salvage. The remaining 10 pa-
tients (42%) in this group underwent BKA after the foot
wound failed to heal. Wound healing and limb salvage were
significantly better in the IPC group (P .01).
The TcPO2 in the supine position was similar between
the two groups at baseline and remained so upon comple-
tion of the study (P  .5). The TcPO2 in the sitting
position on completion of the study was significantly better
in the group receiving IPC (95% CI, 0.001-11.0 mm Hg;
P  .0038). Comparison of the TcPO2 between the two
groups at the end of the study was conducted on the basis
of TcPO2 estimations performed before lower extremity
amputation occurred. There was no difference in the ABIs
between the two groups on study completion, obtained
again just before extremity amputations were performed.
More than 83% (20 of 24) of patients in the IPC group
complied fully with the allotted IPC treatment schedule. The
remaining four used IPC less often than the time originally
agreed upon (a minimum of 6 hours of IPC application per
day), but no less than 75% of that time. Assisting compliance
of IPC application was the clinical improvement that the
f infrainguinal arterial bypass grafting in the two study
IPC Group (n24)
ency (%)
Anastomotic/graft
Stenosis  50%
s (100%) 1 in 4 limbs (25%)
mbs (87%) 8 in 13 limbs (62%)
s (86%) 4 in 6 limbs (67%)
s (80%) 2 in 4 limbs (50%)
s (100%) 2 in 3 limbs (67%)
imbs (89%) 9 in 17 limbs (53%)
Control Group (n24)
ency (%)
Anastomotic/graft
Stenosis  50%
s (83%) 2 in 5 limbs (40%)
bs (90%) 5 in 9 limbs (56%)
s (100%) 3 in 5 limbs (60%)
s (67%) 1 in 2 limbs (50%)
s (100%) 2 in 3 limbs (67%)
imbs (87.5%) 7 in 14 limbs (50%)
hat these procedures were not performed in time proximity with the study,
n 5 years.0%) o
Pat
limb
15 li
limb
limb
limb
19 l
Pat
limb
0 lim
limb
limb
limb
16 lpatients so treated felt they had received.
S, no
. Qua
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The data from this controlled study revealed that pa-
tients with chronic CLI and wounds in the foot, due to a
toe or transmetatarsal amputation and tissue loss, refractory
to healing, may be significantly aided in improving their
healing and the likelihood of limb salvage if IPC is provided
as an adjunct to a standard wound care. Within 18 months
of therapy commencement, three times as many patients
with chronic CLI receiving IPC (6 hours per day) as part of
their wound care had their foot ulcers completely healed
(58%) and an equal proportion of limbs salvaged (P .01),
as those in the control group (17%) undergoing an identical
treatment, except IPC, andmatching the former in demog-
raphy, cardiovascular risk factors, and PAD distribution.
These findings come to enhance further the clinical mo-
mentum associated with the use of IPC in PAD.6,7,9-11
Previously, Montori et al10 (2002) had investigated the
effect of IPC among 107 patients (median age, 73 years)
with CLI, of whom 94.4% had leg ulcers, 25% had a history
of amputation, and 64% had diabetes. The etiology was
multifactorial in 64% of wounds, and 60% were associated
with TcPO2 20 mm Hg. Patients used IPC at home on
the affected limb for 6 hours daily.10 Within 6 months,
complete wound healing and limb salvage had been
achieved in 40% of patients with TcPO2 levels 20 mm
Hg, in 48% of those with osteomyelitis or active wound
infection, in 46% of those with insulin-dependent diabetes,
and in 28% of those who had a previous foot amputation.10
These findings are consistent with those by van Bem-
melen et al9 (2001) on 13 consecutive patients (mean age,
76), consisting of 14 legs with CLI (rest pain, 1; tissue loss,
13), who underwent 3-month IPC therapy (4 hours daily),
in the absence of revascularization options owing to lack of
outflow arteries (n 7), lack of autogenous vein (n 5), or
poor general medical condition (n 3).9 They represented
10% of their referrals for CLI, and 62% were diabetic. In the
duration of treatment, nine legs (64%) had a significant
increase (P  .05) in pulse-volume amplitude, and all of
Table V. Surgical outcomes at 18 months follow up in th
IPC) and the control subjects (Group Control)a
Surgical Outcomes Group IPC
Survivorship at 18/12 follow up 20 (83%
Complete healing - limb intact at 18/12 14 (58%
BKA after a failed local amputation 10 (42%
Hemodialysis 2
Peripheral Perfusion
TcPO2 Horizontal 20 9 (37.
TcPO2 Horizontal 20-30 15 (62.
TcPO2 on Sitting 10 2 (8.3
TcPO2 on Sitting 10 to 20 4 (16.
TcPO2 on Sitting 20-40 18 (75%
BKA, below knee amputation; IPC, Intermittent pneumatic compression; N
aDifferences in proportion analysed with the 2 test with Yates correction
Statistical analysis based on the Mann Whitney test.these legs were salvaged.9 The remaining limbs that failedto show any hemodynamic improvement were amputated.
A direct correlation between patient compliance and clini-
cal outcome was documented. Those in whom limb salvage
was achieved made use of IPC for longer (P .05) periods
of time (mean 2.38 hours daily) compared with those who
had limb amputation (mean 1.14 hours daily).9
Promising results with IPC for the management of
chronic CLI were also reported by Louridas et al11 (2002)
in 25 patients, with tissue loss present in 23 limbs, rest pain
in 10, after a failed bypass graft in 9, or with angiographi-
cally diagnosed distal disease that could not be recon-
structed in the remaining.11 At a mean follow-up of 3
months, 19 legs (58%) were saved and 14 (42%) were
amputated, 11 of which were in patients with chronic renal
failure, a known risk factor.11 Excluding this group, the
amputation rate was 13.6% (n  3). Toe pressures after 3
months of IPC had significantly improved (P  .03). The
mortality rate was 12% overall. Among those presenting
with rest pain, 40% improved with IPC. While on IPC
therapy, 26% of the foot ulcers healed.11
Assessment of the hemodynamic efficacy of IPC of the leg
(120mmHg for 4 seconds, three times per minute) at a micro-
circulatory level with laserDoppler fluxmetry, had been reported
togenerate a significant increase in the skinbloodflux(P .001)
at the pulp of the big toe on dependency in patients with critical
or subcritical limb ischemia after femoral–popliteal and femoral–
distal (18 limbseach)bypassgrafting.12 Inacohortof20 limbs in
20 patients with CLI, with 14 limbs characterized as inoperable
and six considered as marginal for reconstruction, IPC leg appli-
cation (120 mmHg, inflation 3 seconds, deflation 17 seconds)
caused flow to increase significantly in the popliteal, gastrocne-
mial, and collateral arterial arteries (18 of 20 limbs) compared
with baseline values (P  .02).13 This was associated with a
significant skin blood flux increase (P  .03). In two limbs
without arterial or skin blood flow enhancement with IPC,
significant popliteal vein reflux was present and both limbs were
amputated shortly thereafter.13
Three physiologic mechanisms have been implicated in
up receiving intermittent pneumatic compression (Group
4) Group Control (n24) Significance
18 (75%) NS
4 (17%) p0.001
20 (83%) p0.001
5 NS
12 (50%) NS
12 (50%) NS
10 (42%) p0.01
7 (29%) NS
7 (29%) p0.01
nstatistically significant; TcPO2, transcutaneous oximetry.
ntitated non-paired data comparison between the two groups performed.e gro
(n2
)
)
)
5%)
5%)
%)
6%)
)explanation of the leg inflow enhancement with IPC in PAD:
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suspension of peripheral sympathetic autoregulation, and (3)
enhanced release of nitric oxide with flow and shear-stress
increase.7,16 Arteriovenous pressure-gradient enhancement
with IPC could not be disputed in CLI,17 forming the sub-
strate empowering ignition of the other two mechanisms.7,16
As interstitial pressure in the leg increases with the delivery of
a pneumatic impulse, the walls of underlying veins collapse,
ejecting venous blood up in the thigh and causing venous
pressure to decrease transiently, until veins are refilled by
forward flow from the arteries.7,16-18 An increase in the hy-
drostatic pressure gradient during this brief transitional period
postcompression is thought to be a major mechanism for the
enhancement of the arterial leg inflow.5,7,16-18
A direct reduction in peripheral resistance has also been
postulated by release of nitric oxide, secondary to shear stress
increase in the venous radicles with IPC, the action of which
on the adjacent arteriolar resistance vessels by local diffusion
causes them to dilate transiently with concurrent flow en-
hancement.5,7,16,19,20 In an in vitro cell culture system de-
signed to simulate blood flow and vessel collapse conditions
during IPC, Northern blot analysis of messenger RNA in
endothelial cells revealed an up-regulation of tissue plasmino-
gen activator and nitric oxide synthase expression.19,20
Transient suspension of the venoarteriolar reflex, an axon
sympathetic reflex autoregulating arteriolar resistance, is prob-
ably an additional mechanism of peripheral resistance attenu-
ation during IPC.21,22 The unstretched baroreceptors of the
emptied venous radicles, immediately after impulse delivery,
transiently cease igniting their vasoconstrictor effect through
the reflex until priming of the refilling veins causes the barore-
ceptors to stretch again.21-26 Peripheral sympathetic autoreg-
ulation is considered largely abolished in CLI,21 yet epidural
anesthesia and analgesia27 and the administration of prosta-
glandins,28,29 both causing attenuation of peripheral flow
resistance with vasodilatation, have been reported to offer an
appreciable clinical improvement, thus contradicting the con-
tention of peripheral vasoparalysis in CLI.
It has been purported that an aggressive approach to
arterial revascularization is justified on humanitarian and
socioeconomic grounds.30-32 With the aging population in
Western societies and thus the increasing prevalence of CLI
with age, the financial implications of limb salvage, revas-
cularization, or otherwise, are most substantial, with sav-
ings estimated to exceed US $40 million per annum in the
United Kingdom.33,34 However, repercussions on quality
of life are probably of an even higher order, because elderly
amputees are less likely be mobile with a prosthesis.35-37
Examining the association between limb salvage and recon-
struction in patients with CLI aged70 years, Eskelinen et al38
(2003) reported1976major amputationspermillion inhabitants
when infrapopliteal bypass surgery wasmethodically pursued for
severePADcomparedwith3177permillionwhen infrapopliteal
bypass surgery was performed as a last resort to preventing limb
loss.38 In a 20-year perspective of the patient and procedural
variables in infrainguinal reconstruction in a tertiary practice
(1978-1997), an increasingly complexmedical and surgical chal-
lenge was documented when compared with the previous de-cades pertaining to a significant increase in the age, female sex,
diabetesmellitus, renal failure, prior coronary artery bypass graft-
ing, technical complexity, tissue necrosis as the indication for
surgery, more distal levels of outflow, and the use of ectopic or
synthetic graft material.39 These clearly indicate the need for
methods that would be able to reverse perfusion in CLI when
arterial reconstruction surgery is exhausted.
Onthebasisof thedataof thecurrent report, addingtothose
by previous accounts,9-11 IPC appears to be able to enhance
tissuehealing and limb salvage inpatientswithCLI, secondary to
perfusion augmentation. AlthoughTcPO2 determination is sus-
ceptible to ahostof confoundingvariables, the importanceof the
information derived is substantial, reflecting cutaneous blood
flow, metabolic activity, oxyhemoglobin dissociation, and oxy-
gen diffusion through the tissues.40 The TcPO2measurement is
most sensitive to higher grades of arterial obstruction and tissue
perfusion impairment. The substantial increase of TcPO2 in the
IPC group on dependency may indicate a far better balance
between oxygen supply and the metabolic demand of the isch-
emic tissuesafter therapywithIPC.Severearterial foot inflowand
sympathetic autoregulation impairment is likely implicated in the
improvement of TcPO2 on dependency alone among the pa-
tients of the IPC group. Other investigators have associated the
clinical improvement of CLI after IPC, with pulse-volume am-
plitude9 and toepressure11 corroboratingdistal arterial perfusion
enhancement.
In addressing plausible limitations of the present study, its
retrospective controlled design would certainly not be able to
provide the robustness of evidence that a prospective, ran-
domized controlled design could yield. Nonetheless, the
study aimed to contribute further to our understanding of the
clinical and hemodynamic efficacy of IPC in patients with
CLI, with data never previously published to our knowledge.
Those who agreed to receive IPC might represent those with
a more aggressive or adventurous mindset, or both, seeking
resolution of their physical problem more emphatically than
those who declined IPC. Conversely, study groups consisted
of demographically matched patients of the same geographic
region who had sought optimal care at our nonpublic institu-
tion before and during the active ulcer period aided in bridg-
ing plausible social or economic discrepancies, or both. A
better control group would have been put on IPC for 6 hours
daily, but without active compression; yet those acting as the
control group would not have agreed to such an option.
Finally, the clinical efficacy of other IPC modes (ie, IPC of
foot, IPC of foot and calf) or optimal duration of IPC use, or
both, could not be addressed in the framework and study
population of the present study.
CONCLUSION
By enhancing the leg inflow and the metabolic balance of
tissue oxygen supply to its demand, IPC has been found to
promote the healing process and to improve limb salvage in
patients withCLIwhen revascularization options are unavailable
or exhausted and established treatment alternatives in current
practice are lacking. These encouraging data are in support of
large-scale multicentric studies aiming not only to substantiate
the exact indications and the actual clinical benefit but also to
JOURNAL OF VASCULAR SURGERY
Volume 47, Number 3 Kavros et al 549promoteour insight into theunderlyingphysiologicmechanisms
that facilitate these IPC-dependent outcomes.
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